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This article describes the cellular sources for tyramine and the cellular targets of tyramine
via the Tyramine Receptor 1 (AmTyr1) in the olfactory learning and memory neuropils
of the honey bee brain. Clusters of approximately 160 tyramine immunoreactive
neurons are the source of tyraminergic fibers with small varicosities in the optic
lobes, antennal lobes, lateral protocerebrum, mushroom body (calyces and gamma
lobes), tritocerebrum and subesophageal ganglion (SEG). Our tyramine mapping study
shows that the primary sources of tyramine in the antennal lobe and calyx of the
mushroom body are from at least two Ventral Unpaired Median neurons (VUMmd
and VUMmx) with cell bodies in the SEG. To reveal AmTyr1 receptors in the brain,
we used newly characterized anti-AmTyr1 antibodies. Immunolocalization studies in
the antennal lobe with anti-AmTyr1 antibodies showed that the AmTyr1 expression
pattern is mostly in the presynaptic sites of olfactory receptor neurons (ORNs). In the
mushroom body calyx, anti-AmTyr1 mapped the presynaptic sites of uniglomerular
Projection Neurons (PNs) located primarily in the microglomeruli of the lip and basal
ring calyx area. Release of tyramine/octopamine from VUM (md and mx) neurons
in the antennal lobe and mushroom body calyx would target AmTyr1 expressed on
ORN and uniglomerular PN presynaptic terminals. The presynaptic location of AmTyr1,
its structural similarity with vertebrate alpha-2 adrenergic receptors, and previous
pharmacological evidence suggests that it has an important role in the presynaptic
inhibitory control of neurotransmitter release.
Keywords: biogenic amine receptors, G-protein coupled receptors, tyramine, learning and plasticity, olfactory
pathways
INTRODUCTION
The biogenic amines tyramine and octopamine are neuroactive compounds that are involved
in a large repertoire of invertebrate behaviors, including locomotion, sensory processing,
learning and memory (Roeder, 2005; Scheiner et al., 2006; Lange, 2009). Since Erspamer and
Boretti (1951a,b) first described octopamine in the salivary gland of the octopus as having
‘‘adrenaline-like’’ action, many studies have demonstrated the important role octopamine and
its biosynthetic precursor tyramine play in invertebrate physiology and behavior. The source of
octopamine was mostly allocated to the paracrine cells, the so-called dorsal (ventral) unpaired
median (DUM/VUM) neurons, first described by Plotnikova (1969). Due to their location on
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the midline of the ventral nerve cord and brain, and to
their unique morphology, Hoyle (1974) proposed that these
octopaminergic neurons are involved in the modulation of many
types of behavior.
Tyramine is synthesized from tyrosine by the enzyme
tyrosine decarboxylase, and then octopamine is synthesized
from tyramine in one step by the action of enzyme tyramine
beta-hydroxylase (David and Coulon, 1985). Until recently,
tyramine was thought only to be the precursor of octopamine,
without playing any other significant role. Studies of tyramine
and its receptors in invertebrates clearly indicated that
tyramine has sources and functions independent of octopamine
(Kutsukake et al., 2000; Roeder et al., 2003; Alkema et al.,
2005; Roeder, 2005; Lange, 2009; Bayliss et al., 2013; Scheiner
et al., 2014; Ishikawa et al., 2016). In the locust, tyramine is
expressed in all neurons that express octopamine as well as
in some cells that do not express either the beta-hydroxylase
enzyme or octopamine (Kononenko et al., 2009; Homberg et al.,
2013). Studies in the fruit fly larval central nervous system
also reported the presence of tyramine-containing neurons
that are distinct from octopaminergic neurons (Nagaya et al.,
2002).
Tyramine and octopamine trigger intracellular signaling
pathways by binding with different affinities to a variety of
octopamine receptors (OARs) or tyramine receptors (TYRs),
most of which are G-protein coupled receptors (GPCRs;
Grohmann et al., 2003; Balfanz et al., 2005; Hauser et al.,
2006). There are four different classes of invertebrate GPCRs
that bind octopamine and/or tyramine (Evans and Maqueira,
2005; Maqueira et al., 2005; Verlinden et al., 2010; Bayliss
et al., 2013; Balfanz et al., 2014). Alpha-adrenergic-like OARs
(OctαRs/OA1), beta-adrenergic-like OARs (OctβRs/OA2),
octopamine/tyramine (Oct/Tyr/TyrR I) receptors, and TyrR
II (Verlinden et al., 2010). When it binds with octopamine,
AmOA1 releases calcium from cytosolic stores (Grohmann et al.,
2003). The OA2 receptor stimulates adenylyl cyclase activity,
which leads to an increase of 3,5–cyclic monophosphate (cAMP;
Robb et al., 1994; Roeder, 1999; Maqueira et al., 2005; Balfanz
et al., 2014). TyrR I (in the honey bee, AmTyr1 or AmTAR1)
preferentially binds to tyramine and inhibits adenylyl cyclase
activity. TyrR II (in the honey bee AmTAR2) can mediate
calcium signaling and/or affect cAMP levels (Blenau et al.,
2000; Verlinden et al., 2010; Ohta and Ozoe, 2014; Reim et al.,
2017).
AmTyr1 has been cloned and characterized (Blenau et al.,
2000; Blenau and Baumann, 2001, 2003). Earlier localization
studies using in situ hybridization indicated that AmTyr1 is
expressed on cell bodies of mushroom body Kenyon cells (KCs)
and in the antennal lobe (Mustard et al., 2005). In the cockroach,
PeaTyr1 is expressed in abundance in all brain neuropils as well
as in peripheral tissues such as the salivary glands (Rotte et al.,
2009). A recent study by Reim et al. (2017) characterized the Apis
mellifera TYR type 2 (AmTAR2). The authors provide evidence
that AmTAR2, when heterologously expressed in flpTM cells,
exclusively causes an increase in cAMP.
Here we use immunocytochemistry to describe the
localization of tyramine and its receptor AmTyr1 in the
olfactory networks of the antennal lobe and mushroom bodies.
We focused on AmTyr1 because it has been implicated in genetic
studies of foraging and reproductive behaviors as well as in
olfactory learning in honey bees (Chandra et al., 2010; Wang
et al., 2012; Scheiner et al., 2014). The antennal lobe of the honey
bee is the anatomical and functional analog of the vertebrate
olfactory bulb (Hildebrand and Shepherd, 1997). The antennal
lobe consists of an aglomerular neuropil that is surrounded by
160 glomeruli, where each glomerulus participates in coding
for a subset of odors. The cortex—the outer rind—of each
glomerulus receives olfactory receptor inputs from axons of
olfactory receptor neurons (ORNs). Each glomerulus contains
dendrites of Projection Neurons (PNs), axons from which
then connect the antennal lobe to higher order processing
centers—the lateral horn (LH) and mushroom body calyx. The
PN dendrites in the core of a glomerulus receive synapses from
local neurons (Sinakevitch et al., 2013). The mushroom bodies
are higher order olfactory processing centers. They contain
intrinsic neurons—the KCs—that have cell bodies packed
around the mushroom body calyces. The dendrites of KCs in
basal ring and lip of the calyces receive olfactory and gustatory
afferents (Strausfeld, 2002). The dendrites of KCs in the collar
area of the calyx receive visual afferents. KCs axons make up
the peduncle and mushroom body lobes: vertical, medial and γ
(Strausfeld, 2002).
Tyramine release in the antennal lobe and mushroom body
could modulate this network at several points, but the precise
anatomical distribution of tyramine and its receptors has not
been analyzed in detail, except for a publication contemporary
to ours (Thamm et al., 2017). In our study, we used antibodies
against conjugated tyramine to show its immunolocalization, and
we compared the distribution of anti-tyramine staining to the
distribution of octopamine staining published in earlier work
(Kreissl et al., 1994; Sinakevitch et al., 2005). We also generated
and characterized antibodies against AmTyr1 protein and used
them to identify the distribution of the AmTyr1 receptor on
neurons that are critical components of the olfactory circuitry.
Our study shows how tyramine via AmTyr1 is poised to
modulate odor processing at different points in the honey bee
brain.
MATERIALS AND METHODS
Animals
Honey bees (Apis mellifera L.) were adult New World Carniolan
foragers of unknown age obtained from colonies maintained at
Arizona State University. The bees were collected at the entrance
of the hive when they returned from the field with pollen, usually
in the afternoon.
Anti-Tyramine Staining
Tyramine antiserum (AB124; EMD Millipore) was raised in
rabbits using p-tyramine conjugated to N-alpha-acetyl-L-lysine-
N-methylamide using glutaraldehyde (Geffard et al., 1984b).
This antiserum has been used in the locust and fruit fly to
describe tyramine-like immunoreactivity in the brain (Nagaya
et al., 2002; Kononenko et al., 2009; Homberg et al., 2013).
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Antiserum specificity of immunostaining was tested using
tyramine/octopamine conjugated to bovine serum albumin
(BSA). The conjugates were prepared as described elsewhere
(Geffard et al., 1984a; Mons and Geffard, 1987). Brains
were dissected out of the head in fixative containing 3%
glutaraldehyde (Electron Microscopy Sciences (EMS), Hatfield,
PA, USA) in 0.1 M cacodylate buffer (EMS, pH 7.0) with
1% sodium metabisulfite (SMB, Sigma-Aldrich, St.Louis, MO,
USA). Each dissected brain was then transferred into 1 ml of
fresh fixative and left overnight at 4◦C. To saturate double
bonds, after fixation the brains were treated with 0.5% sodium
borohydride (NaBH4; Sigma-Aldrich) in 0.05 M Tris-HCl buffer
containing 0.45% SMB (Tris-HCl-SMB; Sigma), pH 7.4 for
20 min. After washing with Tris-HCl-SMB buffer (4 × 10 min),
the brains were embedded in 8% agarose (low melted point
A0169, Sigma-Aldrich) in water. Brain sections (70 µm)
were made with a Vibratome Leica 1000S (Leica Biosystem,
Germany).
Brain sections were washed (6 × 20 min) in Tris-HCl-SMB
buffer containing 0.5% Triton-X100 (TX) and were incubated
with 1% normal donkey serum (Jackson ImmunoResearch
Laboratories) in Tris-HCl-TX for 15 min. Then, tyramine
antiserum was added to a final dilution of 1:500 to each brain
and left for 48 h. After washing in 0.05 M Tris-HCl-TX, pH
7.5 (6 × 20 min), F(ab’)2 fragments of donkey anti-rabbit
IgG conjugated to Cy3 (Jackson ImmunoResearch Laboratories,
diluted 1:250 in Tris-HCl-TX) were applied as the secondary
antibody overnight. All incubations were at room temperature.
After final washing in 0.05 M Tris-HCl pH 7.4 (6 × 20 min)
sections were mounted on slides in 80% glycerol in phosphate-
buffered saline (PBS) mix.
To test the specificity of tyramine immunostaining,
working dilutions of the anti-tyramine antibodies were
preincubated overnight without and with tyramine conjugated
to BSA, (10−4 M concentration of tyramine in the conjugate,
Figures 1A,B). After preincubation of the primary antiserum
with tyramine-G-BSA, anti-tyramine staining was absent
(Figure 1B). However, after preincubation of the antibodies
with octopamine-G-BSA (10−4 M concentration of octopamine;
Figure 1C), immunolabeling in the cell body and fine processes
was present. Therefore, the working dilution of the tyramine
antiserum specifically recognizes tyramine in cell bodies and
their processes in fixed honey bee brain sections. Twenty bee
brains were processed and analyzed in our studies, eight brains
that were fixed and processed on the same days were used to
count cell bodies (Table 1).
Immunocytochemistry with Anti-Synapsin
Antibody
Immunocytochemistry with mouse monoclonal anti-synapsin
antibody (SYNORF1; clone 3C11, Developmental Studies
Hybridoma Bank, The University of Iowa) was used to label
the synaptic neuropil in brain whole-mounts according to
the protocol of Brandt et al. (2005). Brains (n = 3) were
fixed in 4% paraformaldehyde in PBS overnight, washed in
PBS containing 1% Triton-X (PBS-TX), preincubated 1 h with
normal donkey serum, and then the anti-synapsin antibody
1:1000 was applied for 3 days at room temperature under
gentle shaking. After six washes of 1 h each with PBS-
TX, the brains were incubated with the secondary antibody
(F(ab’)2 fragments of donkey anti-mouse conjugated to Alexa
488, Jackson ImmunoResearch Laboratories) diluted 1:250 in
PBS-TX for 2 days at room temperature. After final washing in
PBS, the whole-mounts were dehydrated, cleared and embedded
in methyl salicylate. The whole-mount brains were embedded
in methyl salicylate for observation (n = 3). To illustrate the
location of the anti-tyramine staining cell bodies, we used
the consecutive protocol staining technique on sections. Three
brains that were sectioned and labeled with anti-tyramine were
post-fixed for 20 min with 4% paraformaldehyde, and then
brain sections were processed for anti-synapsin immunostaining
as described above to obtain tyramine immunoreactive cell
bodies in the sections with the labeled synaptic structure of
neuropil (n = 3).
FIGURE 1 | Controls for immunolabeling with tyramine antiserum. We used three sections of the subesophageal ganglion (SEG) that contain ventral median group
cells (VUM). The sections were labeled with one of the following: (A) tyramine antiserum; (B) tyramine antiserum pre-incubated with conjugated tyramine-bovine
serum albumin (BSA); (C) tyramine antiserum pre-incubated with octopamine-BSA. Scale bar: 25 µm.
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TABLE 1 | The number of tyramine-like immunoreactive neurons in clusters of cells in the brain and subesophageal ganglion of Apis mellifera1,2.
Bee N = 8 Neuropils supplied in Apis
No. of cells on each side
Cluster G0 3 (10) NCC1
Cluster G0b None
Cluster G1 None
Cluster G2a 6 (25) EB, FB, M Pro (circum Ped, V Lo, α lobe ?
Cluster G2b 5 (10) V-M Pro
Cluster G3a 6 (25) + 3 (15) L Pro, Op Lo, Oc N, PB, FB, γ lobe?
Cluster G3b 2 (15) L Pro
Cluster G4a 2 (10) PB and EB
Cluster G4b 16 (10) + 1 (25) PB, EB, D-M Pro
Cluster G4c 2 (15) L Pro
Cluster G4d 4 (8)
Cluster G5a None
Cluster G5b 5 (25) + 5(8) L Pro, M Pro, Ant Mech, Ant nerve, sub CB, OpLo
Cluster G6a 3 (25) Deu, Trito, Ant N? SEG
Cluster G6b 3 (10) SEG
Ventral unpaired median
(VUM) neurons mandibular 83 (25) SEG Md Neuromere, Trito L Ho, Ca, Ant Lo, Ant Nerve, NCC1?
VUM neurons maxillary 83 (25) SEG, L Ho, Ca, Ant Lo, L Pro, SEG, Mx nerve
Ventral paired median (VPM) neurons 23 (25) L Pro, M Pro, NCC1?
VUM neurons labial 83 (25) SEG Labial Neuromere, NCC1
DUM neurons labial 23 (25) ?
1The terminology used for cell groups is the same as in Sinakevitch et al. (2005). 2The approximate sizes of cell bodies are shown in parenthesis in µm. 3Total number of
cell bodies on midline of SEG. NCC, nervii corpora cardiacii; FB, fan-shaped body; EB, ellipsoid body; PB, protocerebral bridge; D, L, M, or V Pro, dorsal, lateral, medial,
or ventral protocerebrum; Ant Lo, antennal lobe; Op Lo; SEG, subesophageal ganglion; Trito, tritocerebrum, Deu, deutocerebrum (other than Ant Lo and Ant Mech); Ant
Mech, antennal mechanosensory neuropil; sub CB, neuropil beneath ellipsoid and fan-shaped body; circum Ped, protocerebral neuropil surrounding pedunculus and
vertical lobe (V Lo); α and γ division of mushroom body vertical lobe; L Ho, lateral horn of protocereberum; Ca, calyx; Oc N, ocellar nerve.
Three Dimensional (3D) Model
of the AmTyr1 Receptor Structure
The structural model of AmTyr1 (NCBI Reference Sequence:
NP_001011594.1) was generated by I-TASSER (Zhang, 2008; Roy
et al., 2010; Yang and Zhang, 2015; Yang et al., 2015) based
on the top 10 proteins from the PDB that have the closest
structural similarity. Besides the threading-based restraints, no
additional external restraints were specified. Molecular graphics
and localization of the antigenic peptides were performed with
the UCSF Chimera package (Pettersen et al., 2004) developed by
the Resource for Biocomputing, Visualization and Informatics at
the University of California, San Francisco.
Anti-AmTyr1 Receptor Antibody
Design of Conjugated Peptides and Antibody
Production
Anti-AmTyr1 receptor antibodies were produced in two rabbits
immunized with two peptides from the N-terminus of AmTyr1
(H2N-TEDYDMTGCGPPEEET-amid (peptide-1, P1) and H2N-
PEELEPGTPCQLTRRQG-amide (peptide-2, P2) conjugated to
Keyhole limpet hemocyanin (KLH; Figure 2A). After four
immunizations, serum from two rabbits was collected and
affinity purified. All these procedures were performed by 21st
Century Biochemical Incorporation (Marlboro, MA, USA).
Western Blot
The affinity purified anti-AmTyr1 antibody raised against
peptide-1 and peptide-2 were further characterized by western
blot (Figure 2B). The brains were dissected and processed
for membrane protein extraction. Each individual brain was
homogenized in 100 µl of lysis buffer (120 mM Tris-HCl,
2% sodium dodecyl sulfate (SDS), 5% glycerol, 0.2 mM
dithiothreitol, 1% Triton X100 containing 5 µg/ml of each
protease inhibitors PMSF (Phenylmethylsulphonylfluoride),
Aprotinin, Benzamidine (all from Sigma-Aldrich) pH 6.8).
Homogenates were centrifuged at 12,000 g for 20 min at
4◦C. Then 30 µl (1/3 of a bee brain) of the supernatant
was added with 6 ×Laemmli buffer and loaded on a 7.5%
SDS-polyacrylamide Tris-glycine gel to separate the proteins.
Proteins were transferred onto nitrocellulose membranes (Bio-
Rad Laboratories) in transfer buffer (25 mM Tris-HCl,
192 mM glycine, 15% methanol) at 0.45 amp for 1 h
30 min at 4◦C. Then the membranes were blocked for
1 h in PBS containing 0.1% Tween-20 (PBS-Tw) and 5%
low fat powdered milk. Then they were incubated with
anti-AmTyr1 antibody raised against conjugate of peptide-1 and
peptide-2, each on separate membrane at 1:1000 in PBS-Tw
plus 5% milk for 4 h at room temperature. Following four
15 min washes in PBS-Tw with 5% milk, membranes were
incubated with anti-rabbit IgG HRP-conjugated secondary
antibodies (Rockland Inc.) at 1:10,000 in PBS-Tw with 5%
milk for 2 h. Membranes were washed four times in
PBS-Tw and developed using chemiluminescence as described
by the manufacturer (Immobilon Western Chemiluminescent
HRP Substrate; Millipore Corporation). The preadsorption
control was done with the corresponding peptide-conjugated
to KLH with each anti-AmTyr1 antibodies where the peptide
concentration was approximately 10−5 M. In these procedures,
anti-AmTyr1 + 1 × 10−5 M peptide-KLH were incubated for
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FIGURE 2 | Characterization of anti-AmTyr1 antibodies. (A) Predicted structural model of the Apis mellifera tyramine receptor (NP_001011594.1). Peptides (P1, P2)
from the N-terminal region and the loop between helices 4 and 5 used to generate the antibodies are represented by their amino acid sequence (pink). (B) Affinity
purified anti-AmTyr1 antibodies against peptide-1 and peptide-2 were tested in western analyses. The relative positions of molecular weight (MW) standards in kDa
are indicated. The affinity purified anti-AmTyr1-P1 and anti-AmTyr1-P2 each revealed a band corresponding to an approximate molecular weight of 45 KDa.
Preincubation of the anti-AmTyr1 antibodies separately with corresponding peptide conjugates abolished the band. (C) Anti-AmTyr1 immunostainings in the antennal
lobe revealed processes in the cortex of glomeruli on frontal section of the brain. (D) In the next consecutive section, staining in glomeruli was not present when the
anti-AmTYR1 antibodies were pre-incubated with Keyhole Limpet Hemocyanin (KLH)-conjugated peptide-1 before immunostaining. (E) Expression of AmTyr1gene in
brains injected with 70 nl of 100 µM dsiAmTyr1 RNA or dsiScramble 14 h after treatments. AmActin was used as a reference gene. The relative gene expression was
calculated using the 2−∆∆Ct method. The data are expressed as mean ± SE. (F) Anti-AmTyr1 staining in the brain section 18 h after injection dsiAmTyr1 RNA (G) and
dsiScr. Arrows in (F,G) indicate injections sites in the frontal sections of the bee brains. (H) Quantification of the average fluorescence intensity value in the box X (Fx),
outlined in F in the raw images of brains that were injected with dsiTyr1 and dsiScr. Images were collected with a confocal fluorescent microscope with the same gain
settings and intensity level. Relative intensity level of fluorescence dropped to 42 ± 5% (mean ± SE) in the dsiTyr1 injected brains compared to dsiScr brains in the
local area of the injections. Scale bar: C,D = 10 µm, F,G = 100 µm.
2 h at 37◦C with gentle shaking. Then after centrifugation
for 10 min at 10,000 g at 4◦C, the supernatant was applied
on the membrane and processed as described above. This
treatment abolished staining on the membrane for both
antibodies.
Anti-AmTyr1 Staining
For all immunostaining on bee brain sections, we used the
anti-AmTyr1 antibodies that were raised against the peptide-1,
and the protocol for testing their immunostaining specificity on
bee brain sections is described below.
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Honey bee forager brains were removed from the head capsule
under fixative containing 4% paraformaldehyde in PBS, then
each brain was placed in one milliliter of the same fixative
overnight at 4◦C. The next morning, brains were washed in
PBS and embedded in 8% agarose. Each agarose block was
sectioned (70 µm) and processed for immunostaining. First,
brain sections were preincubated with 1% normal donkey serum
and then anti-AmTyr1 (affinity purified polyclonal antibodies
raised against the peptide-1 in rabbit) at 1:500 dilution in the
PBS-0.5%TX solution was added to each brain. To visualize
the staining, F(ab)’2 fragments of donkey anti-rabbit IgG
conjugated to Cy3 were used at a dilution of 1:500. After
each step, there were at least six washes of 20 min each
in PBS-TX (6 × 20 min). PBS only was used in the final
wash before embedding brain sections on a glass slide. Twenty
brains were processed with anti-AmTyr1 antibodies in these
experiments.
Characterization Specificity of Immunostaining
of anti-AmTyr1 (Affinity Purified Antibodies Raised
Against Peptide-1) on Bee Brain Sections
To examine the specificity of immunostaining of the
anti-AmTyr1 antibodies, sections were incubated with the
secondary antibody in the absence of primary antibodies
(not shown) or immunoassay with working dilution
of anti-AmTyr1 (Figure 2C) or anti-AmTyr1 antibody
that had been preincubated with KLH conjugated to
AmTyr1 peptide-1 via glutaraldehyde (Figure 2D). In these
procedures, anti-AmTyr1 and anti-AmTyr1 + 2 × 10−4 M
peptide-1-KLH were incubated for 2 h at 37◦C with
gentle shaking. Then after centrifugation for 10 min at
10,000 g at 4◦C, the supernatant of each solution was
applied on two consecutive sections and processed as
described above. All procedures were performed at room
temperature unless otherwise noted. Images of sections
treated with anti-AmTyr1 antibody preincubated with
conjugated peptide were collected at the same level of gain
and intensity.
Control for Immunostaining after Knockdown
of AmTyr1
To demonstrate that anti-AmTyr1 antibodies specifically
recognized the receptor, we used a Dicer-substrate small
interfering (dsi) RNA of the AmTyr1 receptor (NCBI Reference
Sequence: NM_001011594.1) to knock down levels of the
AmTyr1 mRNA receptor in the brain (Figure 2E). We used
the mixture of three dsiAmTyr1 designed by the tool in IDT
technology (Table 2), and as a control we used scrambled dsiScr.
Seventy nanoliters (nL) of 100 µM mixture of dsiAmTyr1 or
dsiScr was injected using a picospritzer into the mushroom
body lobe on one side (six bees for each group), and then the
brain without optic lobes was dissected and homogenized in
1 ml of TRIzol (Invitrogen) 13–15 h after injections. Then the
total mRNA from each injected bee brain part was extracted
separately using the manufacturer’s protocol for TRIzol method
(Invitrogen). Contaminating genomic DNA was removed
using DNA-freeTM kit (Ambion, AM1906). RNA quantity and
TABLE 2 | Nucleotide sequences of sense and antisense strands of control
DsiSCR and AmTyr1 DsiRNA.
DsiRNA Sequences
dsiScr 5′-GAGUCCUAAGUUAACCAAGUCACAGCA-3
3′-CUCAGGAUUCAAUUGGUUCAGUGUCGU-5′
dsiTyr1_N 5′-AGCGUGACGUUGGAUUGACGAGAGC-3′
3′-CCUCGCACUGCAACCUAACUGCUCUCG-5′
dsiTyr1_T1 5′-CCUGUGCAAAUUGUGGCUAACCUGC-3′
3′-GUGGACACGUUUAACACCGAUUGGACG-5′
dsiTyr_C 5′-CAACGCUUGUUUAUUGCAUCUAUCG-3′
3′-CCGUUGCGAACAAAUAACGUAGAUAGC-5′
purity was evaluated using a NanoDrop (NanoDrop 2000).
Expression of AmTyr1 was quantified using QuantiFAST SYBR
Green RT-PCR kit (QIAGEN, 204156) on Applied Biosystem
7500 cycler with the exact protocol provided by the 96-well kit.
We used 20–40 ng of RNA per well. The primers for quantitative
real-time PCR assays were characterized and described in Wang
et al. (2012): AmTyr1_F 5′-GTTCGTCGTATGCTGGTTGC-3′,
AmTyr1_R 5′-GTAGATGAGCGGGTTGAGGG-3′ and for
reference gene AmActin_F 5′-TGCCAACACTGTCCTTTCTG-
3′ AmActin_R 5′-AGAATTGACCCACCAATCCA-3′. The
relative gene expression was calculated using the 2−∆∆Ct
method.
To test immunostaining of the AmTyr1 protein, five
dsiAmTyr1 injected brains and five control brains injected with
dsiScr were dissected and fixed 18–24 h after injections, then
processed for anti-AmTyr1 immunostaining as described in
section anti-AmTyr1 staining above (Figures 2F–H). To estimate
the reduction of protein in fixed brain tissue we used the original
raw images of brains injected with dsiTyr1 and dsiScr collected at
the same gain. The area of interest X was drawn on each section
in the place where dsiRNA was injected (Box X in Figure 2F).
The average fluorescence intensity value (Fx) was estimated in
Adobe Photoshop CC 2015 on each sections on the injected side
of the brain. Then statistical analyses and the graph were done in
Origin 6.1 software.
Triple Staining with anti-AmTyr1,
Anti-Synapsin and Neurobiotin Labeled
Neurons
To identify cell types that express AmTyr1 in the antennal lobe,
we labeled ORN and PN terminals by injecting neurobiotin
into the antenna and antennal lobe. For both procedures,
each bee was cooled and placed into a plastic restraining
harness, and the head was immobilized with low melting
point wax. Then each antenna was gently immobilized with
ecosaine, the isomeric hydrocarbons obtained from paraffin wax
(Aldrich).
To label ORN endings in the glomeruli, neurobiotin was
injected into the antenna, where the ORN axons take up the
tracer, which then undergoes anterograde transport to the axon
terminals in glomeruli. For neurobiotin injection into the
antenna, a small hole was cut in the scape at the base of the
antenna, and 50–70 nL of 2% neurobiotin (weight/volume in
water) was injected using a picospritzer. To label ORN cell
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bodies in the antenna, neurobiotin was injected into the antennal
lobe from where the tracer was transported retrogradely to the
cell body and dendritic fibers in the sensory receptor pocket.
4′,6-diamidino-2-pheylindole (DAPI) was used as a fluorescent
marker of cell nuclei in the antenna. Five bees were processed
to trace the ORNs and co-labeled with anti-AmTyr1 and anti-
synapsin.
To label the PN axon terminals we injected neurobiotin
into the antennal lobe, where the PNs take up the tracer and
anterogradely transport it to the mushroom body calyx, where
axons form the synapses in the KC dendritic field. For this
procedure, a small window was cut in the head capsule allowing
access for neurobiotin injection into each antennal lobe. The
bee then was detached from the holder and placed in a small
wooden box with available food (1.5 M sucrose and pollen) and a
humidified environment. The bees were sacrificed the next day
16–20 h after dye injections. Brains were dissected and fixed
as described above for anti-AmTyr1 staining. Five bees were
processed to trace the PNs and co-labeled with anti-AmTyr1 and
anti-synapsin.
To label synaptic neuropil, the anti-synapsin antibody
(dilution 1:1000) was added together with anti-AmTyr1
(1:500) overnight. Then sections were washed, and secondary
antibodies F(ab’)2 fragments donkey anti-rabbit IgG conjugated
to Cy3 (1:250) and F(ab’)2 fragments donkey anti-mouse IgG
conjugated to 488 (1:250) were added to the sections together
with streptavidin conjugated to Cy5 (Jackson ImmunoResearch
Laboratories, 1:250) to reveal anti-AmTyr1, anti-synapsin and
neurobiotin respectively in the brain sections. Preparations
were then thoroughly washed in PBS and embedded in 80%
glycerol. To control the specificity of the secondary antibodies,
all secondaries were incubated with sections that had only
one of the primary antibodies. The staining did not show
any cross-reaction between the secondary antibodies and
Streptavidin-Cy5. Streptavidin-Cy5 did not interact with any
structure in the absence of the neurobiotin in the bee brain.
Confocal Microscopy
Data were collected on a Leica SP5 confocal laser scanning
microscope (Leica, Bensheim, Germany) using a Leica HCX
PLAPO CS 40_oil-immersion objective (numerical aperture:
1.25) with appropriate laser and filter combinations. Stacks of
optical sections at 1 µm spacing were processed using Leica
software (1024 × 1024 pixel resolution) either as a single slice or
flattened confocal stacks (maximum intensity projections). Size,
resolution, contrast, and brightness of final images were adjusted
with Adobe Photoshop software. To generate the general view
of a tyramine-containing cell in the whole brain we used whole-
mount immunocytochemistry with anti-synapsin antibodies.
Serial sections were made at 1 µm using a Leica ×10 objective
and reconstructed to create 3D images of the brain using AMIRA
software (FEI visualization science group). Then the agarose
brain sections labeled with both anti-tyramine and anti-synapsin
were compared with digital serial sections of the whole-mount
brain, and cell bodies were manually added in the appropriate
serial digital layer to create the image of tyramine cell body
distribution in the whole-mount brain (Figure 3A).
RESULTS
Antibodies and Immunolabeling
The tyramine antiserum used in our studies specifically
recognized tyramine, as shown through immunostaining
pre-absorption tests (Figures 1A–C). Anti-tyramine
immunostainings were repeatable across animals, revealing
cell bodies, neurites and varicosities of neurons. The intensity
of anti-tyramine staining in the cell bodies was variable, as
illustrated in Figure 1A for ventral unpaired neurons: staining
ranged from very bright to low intensities. After pre-incubation
of working dilutions of anti-tyramine antibodies with tyramine-
G-BSA, specific anti-tyramine labeling was abolished, as shown
in Figure 1B for SEG frontal sections. When the same working
dilution of anti-tyramine antibodies was preincubated with
octopamine-G-BSA, the tyramine immunoreactive staining in
the cell bodies and processes was still present (Figure 1C). In
total, we treated 20 brains with anti-tyramine antibodies, and
cell counts in Table 1 were based on eight of the brains.
We created a 3D model of the AmTyr1 receptor protein
to show localization of the peptides used for immunization
(Figure 2A). We used I-TASSER that employs composite
approaches of threading, structural refinement, and ab
initio modeling to generate a 3D model of the full-length
AmTyr1 receptor. The best predicted model had a C
(confidence)-score of −0.89, and the estimated TM (template
modeling)-score and RMSD (root mean square deviation) of
0.60 ± 0.14 Å and 8.8 ± 4.6 Å, respectively. Generally, values of
the C-score (typically, in the range of [−5, 2]) and the TM-score
(range of [0, 1]) higher than −1.5 and 0.5, respectively, are
indicative of correct global fold and main chain topology. RMSD
is more sensitive to local errors, and it is not unusual to have
big values for proteins of considerable length. In the light of the
above, the generated model of the AmTyr1 receptor appears to
be of reasonably high accuracy/quality.
The AmTyr1 receptor protein has seven transmembrane
domains with a large intracellular loop between helixes 5 and
6 and a short C-terminus. The peptides used for immunizations
are located extracellularly in the N-terminus and between
helixes 4 and 5 (Figure 2A). After four immunizations, the
AmTyr1 antisera were affinity purified and the anti-AmTyr1
antibodies were further characterized. First, we used western
blotting to analyze anti-AmTyr1 antibodies for both peptides
separately (Figure 2B). We observed one large band in the
Western blot of brain homogenate proteins, and it corresponded
to the predicted weight of the TYR protein 45 kD (Figure 2B)
for both antibodies. Moreover, pre-incubation of anti-AmTyr1-
peptide-1 and anti-AmTyr1 peptide-2 with corresponding
peptide conjugated to KLH abolished the immunolabeling
on Western blot (Figure 2B). In all our AmTyr1 receptor
immunolabeling on bee brain sections, we used only the antibody
raised against H2N-TEDYDMTGCGPPEEET-amid (peptide-1,
P1). Therefore, we used only this antibody in tests for specificity
of immunolabeling.
Control immunolabeling on brain sections revealed that
anti-AmTyr1 was strongly expressed in the cortex of glomeruli
(Figure 2C), and staining was absent after pre-incubation
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FIGURE 3 | Tyramine-like immunoreactivity in the honey bee brain using inverted fluorescence images. (A) Schematic representation of the brain (frontal view) with
the groups of cell bodies labeled with anti-tyramine antibodies. The left and right halves of the schematic demonstrate the caudal and rostral planes of the brain. The
tyramine containing cell groups (magenta) are G2-G6 and VUM. The plane of the sagittal sections on corresponding images (B,E,F,G,J) is indicated by the vertical
lines. (B) The sagittal section through the SEG with anti-tyramine labeled groups of median neurons in mandibular (Md), maxillary (Mx) and labial (Lb) neuromeres with
their primary neurites in corresponding Md (MdT), Mx (MxT) and Lb (LbT) tracts. (C,D) Frontal sections of SEG made via Md (C) and Mx (D) neuromeres respectively,
show corresponding frontal view of VUMmd (C) and VUMmx (D) and ventral paired median (VPM) neurons. The VUM neurons send their primary neurites to the
corresponding tracts, and the secondary neurites branch in the deutocerebrum (circle in C,E). (F,G) Two tyramine immunoreactive axons from VUM neurons, one
from MdN and one from MxN, innervate the antennal lobe (sagittal sections, front on the left) and give rise to ramifications in glomeruli and aglomerular neuropils of
the antennal lobe (G). Asterisk in (F) indicates dorsal lobe. (G) The tyramine immunoreactivity in tract T5-T6 is from unidentified neurons in the tritocerebrum and
SEG. (H) These unidentified tyramine immunoreactive neurons enter into the antennal nerve and are running along the top of the antennal nerve in the sagittal view
and inside of the nerve (frontal view, insert). (I) The secondary neurites from tyramine immunoreactive VUMmd and mx enter in the lateral antenna-protocerebral tract
(l-APT) and innervate the lateral horn (LH) and mushroom body calyx (ca). (J) In the mushroom body calyx, they innervate the basal ring (br) and lip areas, which
receive olfactory afferents from the antennal lobe. The mushroom body pedunculus (ped) and lobe are almost free from tyramine immunoreactive innervation
(I,J,K) except for a few branches in the γ lobe (K) that might originate from LPM neurons from SEG. The arrow in (C) indicates tyramine immunoreactive fibers
running alongside of the esophageal (es) to the corpora cardiaca nerve (NCC). Ant lobe, antennal lobe; ca, calyx of mushroom body; SEG, subesophageal ganglion;
VUM, ventral unpaired median neurons; Ant n, antennal nerve; LPL, lateral protocerbral lobe; APL, anterior protocerebral lobe; AOTu, anterior optic tubercule; V, γ, β,
vertical lobe of mushroom bodies, KC, Kenyon cell bodies. Scale bar: A = 250 µm, B = 50 µm, C–K = 100 µm.
of anti-AmTyr1 with peptide conjugated to carrier protein
KLH (Figure 2D). Furthermore, knockdown experiments using
dsiTyr1 RNA injections in an amount that reduced gene
expression by approximately 50% (Figure 2E) significantly
reduced labeling by anti-AmTyr1 antibodies (Figure 2F). In
contrast, areas where the scrambled construct (dsiScr) was
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injected in the same amount as dsiTyr1 RNA failed to reduce
labeling (Figure 2G). The average level of fluorescence intensity
dropped to 42% in the area close to the dsiTyr1 injection site
compared to the same area around the dsiSCR injection site
(illustrated in Figure 2H). Figures 2F,G illustrate the frontal
sections of the bee brains through the mushroom body vertical
lobes embedded into the anterior protocerebrum. From all of
these experiments, we conclude that the anti-AmTyr1 antibodies
from rabbit specifically recognize the AmTyr1 receptor protein
in Western blots and fixed brain sections.
Distribution of Tyramine Immunoreactive
Cell Bodies and Processes in the Honey
Bee Brain and SEG
The tyramine antiserum labeled clusters of cells in the brain
(Figure 3A) and on the midline of the SEG (Figures 3A–D).
Tyramine containing processes are illustrated in the antennal
lobe (Figures 3E–G) and antennal nerve (Figure 3H), the lateral
protocerebral lobe, the LH, the mushroom body calyces and
lobes (Figures 3I–K) and in the anterior optic tubercule (AOTu;
Figure 3K).
The major tyramine containing fibers in the neuropils of
trito-, deuto- and proto-cerebral ganglia arose from the ventral
neurons located in the midline of SEG (Figures 3A–D). These
anti-tyramine labeled median neurons were classified based
on the position of their primary neurites in tracts within the
three SEG segments corresponding to the mandibular (Md,
Figures 3B,C), maxillary (Mx, Figures 3B,D) and labial (Lb,
Figure 3B) neuromeres, respectively. These neuromeres receive
sensory projections from the nerves of the mouthparts and via
the mandibular, maxillary and labial nerves supply muscles of the
mouthparts involved in the proboscis-extension reflex (Rehder,
1988; Schröter et al., 2007). The SEG is also the relay station for
information in descending and ascending neurons. We focused
our study on median ventral neurons from the mandibular
and maxillary neuromeres. In particular, we focused on the
tyraminergic/octopaminergic ventral unpaired median (VUM)
neurons (VUMmx and VUMmd) that send their symmetrical
secondary neurites in each part of the brain to innervate the
antennal lobe (Figures 3E–G), LH (Figure 3I) and mushroom
body calyx (Figures 3I,J).
The group of anti-tyramine immunostained ventral neurons
in the labial neuromere (Figure 3B) contains at least two dorsal
unpaired neurons (not shown in this illustration). The secondary
neurites from some of these neurons branch in the SEG, and
there are at least two tyramine containing axons in the labial
nerves. The DUM/VUM neurons from the labial neuromere
innervate the labial nerves, the labial neuropil of the SEG and
the corpora cardiaca (Figures 3B,C, Table 1). There were also
tyramine containing axons in the connectives between the SEG
and prothoracic ganglion (Figure 3B).
The mandibular andmaxillary neuromeres each contain eight
anti-tyramine immunoreactive neurons that have a laterally
symmetrical morphology in the SEG and branch in the deuto-
and proto-cerebrum, the antennal nerve and the lateral nerves
(Figures 3E–H). At least two anti-tyramine staining branches are
present in each (mandibular and maxillary) lateral nerve on each
side of the SEG. The anti-tyramine labeled secondary neurites
from some VUMmx and VUMmd neurons travel alongside the
esophageal foramen (circle in Figures 3C,E) and run through the
dorsal lobe and enter to the antennal tracts T5-T6. There were
at least five tyramine containing axons in the ventral antennal
nerve (Figure 3F and insert in Figure 3H). The antennal nerve
also has large anti-tyramine positive varicose fibers on the surface
(Figure 3H).
In our study we were particularly interested in VUMmd1 and
VUMmx1 (Figures 3C,D), because of their importance for
octopamine-driven behavioral conditioning (Hammer, 1993;
Farooqui et al., 2003). They give rise to primary neurites
in the corresponding MdT and MxT tracts and then to
secondary neurites in the deutocerebrum caudal to the
antennal lobe, as illustrated in the frontal section of the SEG
(secondary neurites are circled in Figure 3C) and in the
sagittal section through the left antennal lobe (Figure 3E).
These two VUM neurons send branches into the antennal
lobe (Figures 3F,G). In both Figures 3F,G, the anti-tyramine
immunolabeled sagittal sections through the antennal lobe
illustrate two tyraminergic branches from VUMx1 and VUMd1
(arrows). In Figure 3G, the sections made through the
antennal T1 tracts show that each branch from VUMmx1 and
VUMmd1 gives rise to additional branches that innervate
glomeruli on the dorsal and ventral side of the antennal
lobe (Figure 3G). The anti-tyramine labeled processes in each
glomerulus have varicosities that could be release points for
tyramine not only in glomeruli but also in the aglomerular
neuropil.
The secondary neurites from VUMmx1 and VUMmd1 run
through the lateral antenno-protocerebral tract (l-APT)
(Figure 3I) and give rise to very fine branches in the LH
and the calyx of the mushroom body with highest distribution in
the lip and basal ring of mushroom body calyx (Figure 3J). These
neurons arise from VUMmd1 and VUMmx1 and are identical
to octopaminergic neurons in the same neuromere described in
earlier studies (Schröter et al., 2007). That conclusion is based on
our study with anti-tyramine and anti-octopamine labeling on
the sections. No additional axons were labeled in the antennal
lobe during these procedures [these data are not illustrated here].
The pedunculus and lobe of the mushroom body have
little labeling with anti-tyramine staining, except for a few fine
branches that were distinguishable in the gamma and vertical
lobes (Figures 3I–K). In contrast, all protocerebral neuropils
surrounding the mushroom bodies and lobes contain abundant
tyramine containing varicosities (Figures 3I–K). Tyramine
immunostaining in the mushroom body calyx has its origin from
the VUMmx and VUMmd neurons. However, the mushroom
body lobes are scarcely labeled with tyramine immunoreactivity,
and staining in the gamma lobe originates from the lateral
paired ventral cells (VPM, Figure 3D) as well from unidentified
neurons in group G2. The tyraminergic neurons from group
G3 also innervate the posterior protocerebrum and optic lobes.
The tyramine containing neurons from group G4 innervate the
protocerbral bridge and central complex (Figure 1 for cell bodies
group location and Table 1). The terminology used for tyramine-
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containing cell groups is the same that is described in Sinakevitch
et al. (2005).
Distribution of AmTyr1 Receptor in the
Antennal Lobes and Mushroom Bodies
We used anti-AmTyr1 antibodies to characterize the distribution
of AmTyr1 in the antennal lobe and mushroom bodies
(Figure 4). First, we performed single immunofluorescence
staining in unknown age forager bee brains to identify the
areas in the antennal lobe and mushroom bodies that labeled
with anti-AmTyr1 antibodies (Figure 4). In the antennal
lobe, anti-AmTyr1 staining is unevenly distributed within each
glomerulus as well in the aglomerular neuropil (Figure 4A). High
intensity anti-AmTyr1 staining is localized in the cortex area
in each glomerulus, with low intensity staining in the core of
the glomerulus and in the aglomerular neuropil (Figure 4A).
Anti-AmTyr1 staining is absent in the antennal nerve and tracts
in the antennal lobe (only tract T1 is shown in Figure 4A). Cell
bodies surrounding the antennal lobe also labeled with different
levels of intensity: high intensity labeling is in a subset of the
medial group of cell bodies (asterisk) in Figure 4A. In contrast,
the lateral group of cell bodies is not positive for anti-AmTyr1.
Figure 4B illustrates a section through the mushroom body
and central complex. Anti-AmTyr1 immunostaining is present
in all mushroom body neuropils: calyx, peduncle, and lobes
(Figure 4B). The peduncle and lobes have strong anti-AmTyr1
staining compared with KC bodies and calyx (Figure 4B). The
anti-AmTyr1 labeling in the calyx and lobes is particularly
distinct in the lip, collar and basal ring areas (Figure 4C). The
gamma lobe of the mushroom bodies (staining is shown by
the arrow in Figure 4C) had the most variable anti-AmTyr1
immunostaining distribution. Note that the ellipsoid body and
ocelli also exhibited a high level of anti-AmTyr1 immunolabeling
(Figure 4B).
ORN Axons Express AmTyr1 in the
Antennal Lobe Terminals
To identify the primary cell types that express AmTyr1 in the
antennal lobe we used triple immunofluorescence staining. The
images in Figures 5A1–A5, show triple immunofluorescence
staining in glomeruli with anti-AmTyr1 (magenta, Figure 5A1),
neurobiotin backfills of antennal axons (green, Figure 5A2)
and anti-synapsin (blue, Figure 5A4). Close-ups of ORN
endings in the box in Figures 5A1–A5 is illustrated in
Figures 5B1–B5, respectively. The distribution of anti-AmTyr1
is in the cortex of the glomerulus (magenta, Figures 5A1,B1),
where the ORN terminals are located (green, Figures 5A2,B2).
The endings of ORNs represent varicosities that synapse on
the neuronal processes located in the cortex of the glomerulus.
In the merged image (magenta anti-AmTyr1 and green ORNs,
Figures 5A3,B3), the white color demonstrates co-labeling of
anti-AmTyr1 in the ORN axon endings (Figures 5A3,B3).
Therefore, ORNs containing neurobiotin also have anti-AmTyr1
staining (Figures 5A3,B3). Anti-synapsin also co-labeled the
neurobiotin containing ORNs (Figures 5A4,B5). An example of
staining with anti-AmTyr1 and anti-synapsin in ORNs is shown
FIGURE 4 | Anti-AmTyr1 labeled the neuropil in the honey bee brain. (A) In the
antennal lobe, the anti-AmTyr1 is in the cortex area of each glomerulus, but
not in the glomerular core (c) and not in the aglomerular neuropil (aglom). The
anti-AmTyr1 staining is also absent in the antennal nerve (ant nerve) and
olfactory neuron axons tract T1. Asterisk shows a subset of the AmTyr1
positive medial group cell bodies. (B) All area of mushroom body calyx (ca)
and pedunculus (ped) were labeled with anti-AmTyr1 with various level of
intensity. There is a higher density of staining in the pedunculus (ped) of the
(Continued)
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FIGURE 4 | Continued
mushroom body compared to the lip, collar (co) and basal ring (br) area of the
calyx. Note: the central complex has anti-AmTyr1 staining in the fan shaped
body and ellipsoid body (eb). (C) The mushroom body vertical lobe (V) exhibits
high-intensity level anti-AmTyr1 staining in a basal ring (br), collar (co) and lip
area of the Kenyon cells (KCs) axons that have dendrites in the corresponding
area of a calyx. The illustrations in (A–C) are inverted fluorescence images.
γ—gamma lobe of mushroom body, o-ocelli. Scale bar: A = 50 µm,
B = 75 µm, C = 50 µm.
by the white arrows in Figures 5B1–B5. However, anti-AmTyr1
labeled processes other than ORN axons. The yellow arrows
in Figure 5B1 demonstrate co-staining of anti-AmTyr1 with
anti-synapsin but not with neurobiotin. These data suggest that
other cell types could express AmTyr1 in the cortex of glomeruli,
or possibly not all ORNs were labeled with neurobiotin in our
preparations. Also, due to the limitation of light microscopy
we cannot exclude that AmTyr1 is expressed in processes
of the glomerular cortex that are not co-labeled with anti-
synapsin. More work needs to be done to identify all possible
antennal lobe neurons and/or glial cells expressing AmTyr1. To
reveal ORN cell bodies and dendrites in sensilla, we injected
neurobiotin in the antennal lobe (Figure 6). Then the antenna
was opened and processed for double immunofluorescence
staining to reveal neurobiotin (green) and AmTyr1 (magenta).
The neurobiotin labeledORN cell bodies and processes in sensilla
(Figure 6). Figures 6A,B illustrates a frontal view of antennal
subsegments 5 and 6 of a flagellum. This antenna was not
cut during immuno-procedures, and the images were taken in
a confocal mode with overexposure of all laser channels for
illustration of the surface area of an antenna with different
types of sensilla. The three olfactory sensilla are identified as
sensilla placodea (p in Figures 6A,B), sensilla basiconica (b,
Figure 6B), sensilla trichodea type A (tA, Figure 6B) and type
B1 (tB1, Figure 6B), sensilla trichodea type C (Figure 6A,
tC). In the honey bee, sensilla placodea (or poreplate) house
between 7 and 30 ORNs (Esslen and Kaissling, 1976). To
reveal anti-AmTyr1 and neurobiotin simultaneously in the
antennal processes, antennae were cut with a razor into two
halves and each half processed for staining with anti-AmTyr1,
neurobiotin and DAPI; the latter is the marker for cell nuclei
(Figure 6C). Neurobiotin processes in the sensilla placodea are
not co-labeled with anti-AmTyr1. However, the neurobiotin
filled ORN cell bodies (green Figures 6C,D) co-labeled with
anti AmTyr1 (magenta in Figures 6C,D). The example of
a cell with co-localization with AmTyr1 is indicated by the
arrow in Figure 6D. The anti-AmTyr1 labeled processes in the
sensillum lymph area (Figure 6E1), but they are not co-localized
with neurobiotin labeled dendrites in the sensilla placodea
(Figure 6E2) as demonstrated by the absence of white color in
the merged image (Figure 6E3).
The uPN Terminals in the Calyx of the
Mushroom Body Express AmTyr1
The calyx of the mushroom bodies consists of intrinsic
neuron (KC) dendrites and afferent neuronal terminals of
uniglomerular PNs (uPNs) from the antennal lobe (lip and
basal ring), gustatory inputs (area between lip and collar) and
visual inputs (collar). Interestingly, the gustatory inputs to
mushroom body calyx are from subesophageal neurons, the same
brain region where themodulatory octopaminergic/tyraminergic
VUM neurons originate. In addition, other modulatory neurons
and GABAergic inputs are present in the calycal neuropil. The
organization of the calyx is microglomerular, which reflects
interactions of uPN axons (input) with dendrites of KCs (output)
together with the inputs of inhibitory (GABA) and modulatory
afferent neurons.
Anti-AmTyr1 antibodies labeled microglomeruli in the calyx
of the mushroom bodies (Figure 7A1). The higher magnification
FIGURE 5 | Anti-AmTyr1 labeled synapses of the olfactory receptor neuron (ORN) axons in the antennal lobe glomerulus. (A,B) Triple immunofluorescence labeled
with anti-AmTyr1 antibodies (magenta), neurobiotin tracer in ORNs (green) and anti-synapsin (blue). (B) Images are higher magnifications of details from
corresponding squares indicated in (A). (A1,B1) Anti-AmTyr1 immunostaining expressed in the cortex of glomeruli (magenta). (A2,B2) The ending of the (ORNs,
green) revealed by neurobiotin injections into antenna. Anti-AmTyr1 in glomeruli (A1,A3,A5,B1,B3,B5, magenta) is in ORN endings (A2,A3,A5,B2,B3,B5, green)
co-labeled with anti-synapsin (blue, A4,A5,B4,B5). The white color in merged images (A3,A5,B3,B5) revealed anti-AmTyr1 co-stained in the ORN together with
synapsin. The white arrows in (B1–B5) indicate co-localization with ORN endings by both anti-AmTyr1 and anti-synapsin; yellow arrow shows co-localization
anti-AmTyr1 with synapsin but not with neurobiotin. Scale bar: A = 10 µm; B = 2 µm.
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FIGURE 6 | Anti-AmTyr1 immunostaining in the antennal nerve. (A) General view of the antennal segments 5 and 6, neurobiotin was injected in the antennal lobe,
and the image was obtained by overexposure with the confocal gain to illustrate different types of sensilla (tC–tricoid sensilla type C; Arrow indicates sensilla
placodea (p). (B) Details of the ventral area of the antenna at higher magnification (tA, tB1, tricoid sensilla type A and B1 respectively, b-basiconic sensilla). (C) The
section via antenna illustrates merged images of the group of ORN cell bodies and various processes labeled with neurobiotin tracer (green) anti-AmTyr1 (magenta),
and 4′,6-diamidino-2-pheylindole (DAPI), marking the nucleus, P-indicate the fibers in the sensilla placodea. (D) Images present higher magnifications of details from
corresonding squares indicated in (C). (D1) shows of cell bodies and processes labeled with neurobiotin (green) and anti-AmTyr1 staining (magenta, single staining)
and nuclei (blue, DAPI). (D2) illustrates only neurobiotin labeled processes (green) and nuclei (DAPI, blue). (D3) illustrates only anti-AmTyr1 (magenta) and nuclei
(DAPI). (D4) shows the nuclei staining. The arrow indicates cell bodies that have co-staining with AmTyr1 and neurobiotin. (E) Anti-AmTyr1 (E1 single image,
magenta) is in the area of sensilla placodea (p) with dendrites of ORNs labeled with neurobiotin (green E2). The absence of the white staining in merged image (E3)
demonstrates that AmTyr1 does not co-label dendrites of labeled ORNs. Scale bar: A = 100 µm; B,E = 20 µm; C = 25 µm; D = 10 µm.
in image (Figure 7B1) represents the equivalent of an area
shown in the square box in Figure 7A1 and illustrates a few
of the microglomeruli. The anti-AmTyr1 is in the cortex of the
microglomeruli, but the core is free from immunostaining.
To mark the neuronal structure of uPN terminals in the
calyx microglomeruli, neurobiotin was injected in the antennal
lobe to reveal uPN boutons in the basal ring and lip areas
of the mushroom body calyx (arrows in Figures 7A2,B2).
The dye revealed uPN boutons (Figure 7B2), which are
mainly presynaptic to KC dendrites. As demonstrated in
Figures 7A3,B3, anti-AmTyr1 co-labeled with uPN boutons and
was localized in the periphery of the bouton (white color on
merged images of Figures 7A1,A2,B1,B2). Anti-synapsin labeled
the presynaptic sites of the microglomeruli (Figures 7A4,B4).
When the images (anti-synapsin, anti-AmTyr1 and uPNs
terminals) are merged in Figures 7A5,B5, the white color
demonstrates co-expression of anti-AmTyr1 and synapsin in
the periphery of microglomeruli within the same boutons as
uPNs. Thus, AmTyr1 is localized in presynaptic sites of uPNs in
microglomeruli of mushroom body calyx.
A Subset of Kenyon Cells in the Basal
Ring, Lip and Collar Express AmTyr1 in Cell
Bodies and Axons but Not in the Dendrites
in the Calyx
The mushroom body KC bodies express a low level of
AmTyr1 staining compared to staining in the calyx (Figure 7C1).
The anti-AmTyr1 marks KC bodies in the basal ring, lip and
collar and scattered cell bodies of the gamma lobe with very low
intensity, although it is possible to distinguish a different level
of staining in subsets of cells with higher expression in the basal
ring KCs (Figure 7C1). The anti-AmTyr1 staining is strong in
the vertical mushroom body lobe, especially in the areas that
receive axons from KCs in the basal ring, the collar and the lip
areas. In comparison, staining is much lower in the gamma lobe
(Figure 7D1).
KCs are the intrinsic neurons that make up the mushroom
body. They have dendrites in the calyx and axons in the lobe,
and different types of afferent (input/output) neurons make
their connection to the KCs in the calyx and lobe. To identify
localization of the AmTyr1 receptor in KC dendrites and
axons, we labeled KCs with neurobiotin before immunostaining
procedures with anti-AmTyr1 (Figures 7C2,C3,D2,D3)
and anti-synapsin (Figures 7C4,C5,D4,D5) antibodies.
For neurobiotin injected in the calyx of the cell body layer
(Figure 7C), the area of injection was marked by an ellipsoid in
the peduncle of the mushroom body. The dye was taken up by
subsets of KC bodies and their dendrites in the calyx as well in
the axons in the peduncle (Figure 7C2) and lobes (Figure 7D2).
The neurobiotin-injected KC dendrites in the calyx were not
labeled with anti-AmTyr1. The insert in Figures 7C1,C5 shows
typical AmTyr1 staining in the microglomeruli. In the insert
in Figure 7C2, fine green fibers of KCs are in close proximity
to the AmTyr1 stained PNs, but there is no co-labeling as
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FIGURE 7 | Triple staining with anti-AmTyr1 (magenta) and anti-synapsin (blue) in the mushroom body after neurobiotin injection in uniglomerular projection neurons
(uPNs; green, A,B) and subsets of KCs (green, C,D). (A) Anti-AmTyr1 antibodies (magenta, A1) co-label the neurobiotin injected uPNs ending in the calyx (green,
A2). Arrows in (A2) show the axon from uPNs entering the basal ring and lip area of the calyx and labeling presynaptic parts of microglomeruli. Images in (B) illustrate
at higher magnification microglomeruli indicated by the square in (A1). Arrows in (B) show that single microglomeruli label with anti-AmTyr1 (magenta, B1) in a uPN
terminal bouton (B2). The white staining in merged images (A3,B3) indicates co-labeling of anti-AmTyr1 with uPN terminal microglomeruli. The microglomeruli
labeled with anti-synapsin as a presynaptic marker (A4,B4, blue). The white staining in merged triple staining image (A5,B5) indicates that anti-AmTyr1 and
anti-synapsin are co-labeled in uPN microglomeruli. (C,D) Anti-AmTyr1 labeled microglomeruli (magenta, C1, insert in C1) in the calyx, subsets of KC bodies, the
pedunculus (ped, C1). Also, areas of the mushroom body vertical lobe that correspond to KCs with dendrites in the basal ring, lip and collar areas of the calyx have a
high level of staining intensity (D1). The (KCs) were injected with neurobiotin in the area indicated in (C) by an ellipse, and in single image staining (green, in C2,D2)
the neurobiotin revealed in cell bodies, dendrite in calyx (C2, insert in C2) and in lobe (D2). Only subsets of KCs took up the neurobiotin in this preparation. For the
injection of neurobiotin in the area shown by the ellipse in (C), the subsets of KCs that took up the tracer express it in cell bodies, in dendrites in the lip, basal ring
and collar (C2, insert in C2), and in the axons of the corresponding area of vertical and gamma lobe (D2). Merged images (C3,D3) show the co-localization of KCs
that take up neurobiotin with AmTyr1 in axons but not in the dendrites of the calyx (inserts in C3). (C) AmTyr1 (magenta C1) expression in subsets of mushroom body
KC axons (green, C2) but not in the dendrites in the calyx (insert in C). The merged images in (C5) illustrate co-localization of anti-AmTyr1 with anti-synapsin (blue,
C4 single staining) in calyx microglomeruli, but not with neurobiotin labeled KC dendrites in calyx (insert in C4,C5 respectively). Anti-AmTyr1 in the mushroom body
lobe is in KC axons; these KCs have dendrites in the basal ring and collar areas. In insert (D1)-AmTyr1 (magenta) is in axons of KC labeled with neurobiotin (D2,
single image) and co-labeled with synapsin in (D4; single image). In the triple staining image (D5; insert D5) the white color corresponds to co-labeling of synapsin in
KC axons and AmTyr1. Note, that not all synapsin labeling processes (single staining image D4, insert D4) express AmTyr1 (single staining image D1, insert D1).
Arrows in insert (D1–D5) shows AmTyr1 in the axon of KC co-labeled with synapsin. Scale bar: A,C,D = 50 µm, B = 2 µm.
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demonstrated in Figure 7C3 and in the insert, where the white
color expected for co-labeling in the dendritic area of KCs is
absent. The AmTyr1 receptor is co-expressed in the bundles
of axons of neurobiotin labeled KC in the pedunculus (white
arrow in Figures 7C2,C3). The subsets of neurobiotin labeled
KCs (green bundles in Figures 7C2,C3,C5) could be traced to
the mushroom body basal ring, the collar, the lip and gamma
lobe areas (green in Figures 7D2,D3,D5). KC axons co-express
AmTyr1 in the basal ring, collar and lip area of the mushroom
body (Figure 7D3). The insert of Figures 7D1,D2 show the area
of the lip KC axons in the vertical lobe, where only a few fibers
express receptors as indicated by the yellow arrows in inserts.
The Figures 7C4,D4,C5,D5 show anti-synapsin staining in the
calyx and lobes and anti-synapsin co-labeled with KCs axons in
the pedunculus and lobe, with subsets of KCs that co-express
AmTyr1 in the same axons.
DISCUSSION
Tyramine and octopamine play important roles in insect
behavior by acting as neurotransmitters, neurohormones and
neuromodulators (Roeder, 2005). Their function is analogous
to the adrenergic/noradrenergic system in vertebrates. In the
honey bee (Apis mellifera), the cellular sources of octopamine
(Kreissl et al., 1994; Sinakevitch et al., 2005) and the distribution
of one receptor—AmOA1—has been previously described in
detail (Sinakevitch et al., 2011, 2013). In the current study,
we revealed cellular sources for tyramine and the distribution
of one TYR—AmTyr1—in the honey bee brain by using
immunocytochemistry with tyramine antiserum (Kononenko
et al., 2009; Homberg et al., 2013) and a newly characterized
anti-AmTyr1 antibody.
Tyramine-Immunostaining in the Honey
Bee Brain
A total of approximately 160 tyramine immunoreactive neurons
are organized in different clusters in the brain. They are the
source of tyraminergic fibers with small varicosities in the
optic lobes, antennal lobes, lateral protocerebrum, mushroom
body calyces and gamma lobes, tritocerebrum and SEG. Also,
tyramine-like immunoreactive fibers are present in the antennal
nerve and in the nerve innervating the corpora cardiaca (NCC1).
Since tyramine is a precursor of octopamine, it is not surprising
that our studies revealed that tyramine immunostaining is largely
in the same clusters of cells as octopamine, as previously
described in the honey bee brain (Kreissl et al., 1994; Sinakevitch
et al., 2005). We summarized the cell numbers in Table 1 and
used the same nomenclature of cell groups as Sinakevitch et al.
(2005). According to our present report and comparison with
previous studies on octopamine immunoreactivity in the honey
bee (Kreissl et al., 1994; Sinakevitch et al., 2005), tyramine
containing neurons described here are largely the same as those
that contain octopamine due to the position of their clusters.
We also found differences from earlier studies (Sinakevitch
et al., 2005), as reflected in Table 1. For example, we did not find
tyramine immunoreactive cells in octopamine-positive clusters
G0b, G1 and G5a. It could be that those cells convert tyramine
to octopamine rapidly, such that the tyramine titers are below
detection levels.We also found that there is a higher total number
of cells containing tyramine immunoreactivity in comparison
to octopamine immunoreactive cells reported by Kreissl et al.
(1994) and Sinakevitch et al. (2005). Previous work on biogenic
amine immunostaining reported that handling procedures could
significantly alter octopamine/tyramine levels, and possiblymake
one or both undetectable by immunostaining (Sinakevitch et al.,
2005; Kononenko et al., 2009; Homberg et al., 2013). However,
the differences in numbers of octopaminergic and tyraminergic
neurons in the honey bee brain might also be due to the
presence of neurons that are only tyraminergic. Therefore, due
to the higher number of tyramine-containing cells, and to a
large amount of tyramine-containing profiles in neuropils, our
data suggest that some cells could release only tyramine, some
cells either release only octopamine or co-release both biogenic
amines.
Tyramine Immunoreactivity in the Antennal
Nerve
We also found that the antennal nerve contains tyramine-like
immunoreactivity originating from processes in SEG neurons
that enter the antennal nerve via T5-6. However, it is not
clear what neurons in the SEG could be the source of these
fibers: e.g., the neurons from cluster six or unidentified median
neurons from mandibular and maxillary neuromeres. Tyramine
in the antenna could be in the axons of neurons innervating
the head and antennal muscles, and it could also act as a
hormonal release in the antenna to modulate antennal sensory
neurons. Furthermore, tyramine in the antennal lobe could
also be involved in the regulation and modulation of sucrose
responsiveness (Scheiner et al., 2002). It seems clear, however,
that tyramine does not modulate ORN cell bodies via AmTyr1,
because we did not observe AmTyr1 on the cell bodies of ORNs.
Tyramine Immunoreactivity in the Antennal
Lobe and Mushroom Body
The primary sources of tyramine in the antennal lobe and calyx
of the mushroom body are from at least two median neurons
with cell bodies in the SEG: VUMmd and VUMmx neurons. In
the antennal lobe, these neurons innervate the cortex of each
glomerulus, where ORN axons terminate. They also branch to
the LH and calyx of the mushroom body via the lateral antenno-
protocerebral tract. The entire protocerebral neuropil, except for
the mushroom body lobes, is penetrated by very fine varicosities
of tyramine-containing fibers, and their sources are the VUM
neurons from the SEG as well as the cells from clusters G2 and
G3. The mushroom body lobe has very few tyramine containing
fibers, only a few branches in the gamma lobe are clearly visible,
and the source could be the laterally paired neurons from the SEG
(Schröter et al., 2007).
Also, the presence of tyramine in NCC1 could indicate that
the corpora cardiaca could receive tyramine-containing branches
from some VUM neurons located in the SEG. The morphology
of VUM neurons that give rise to axons in the NCC1 was
previously described in the labial and maxillary neuromeres by
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Eichmüller et al. (1991). While the role of tyramine in NCC1 is
unclear, it could be that tyramine is released from these neurons
to act as a neurohormone, or/and it could control the release of
other hormones from the corpora cardiaca.
AmTyr1 Receptor Structure
Activation of AmTyr1 in heterologous expression systems leads
to reduction of cAMP (Blenau et al., 2000; Reim et al., 2017). Both
tyramine and octopamine reduce cAMP when bound to AmTyr1
(Blenau and Baumann, 2016), but tyramine is more potent than
octopamine. Moreover, AmTyr1 binds yohimbine, which is an
antagonist of the AmTyr1 receptor (Blenau and Baumann, 2001,
2016; Reim et al., 2017). In our 3D model, AmTyr1 has a long
intracellular loop 3 and a short C-terminus. Those properties are
similar to other GPCRs linked to inhibition of adenylyl cyclase
activity; for example, the alpha 2-adrenergic receptors also have
a long intracellular loop 3 and a short C-terminal tails (Kuhar
et al., 1999; Rosenbaum et al., 2009). Based on the structural and
pharmacological properties, AmTyr1 is similar to the vertebrate
type alpha 2-adrenergic receptors, which when activated also
reduce cAMP, and yohimbine has also high affinity of this
vertebrate receptor type. The function of vertebrate-type alpha
2-adrenergic receptors is primarily for inhibitory presynaptic
control of the release of norepinephrine, ATP and acetylcholine
from the nerve (Rosenbaum et al., 2009).
AmTyr1 Receptors Are Expressed in the
Presynaptic Sites of ORN and uPN Axons
The anti-AmTyr1 antibodies we used specifically recognize the
AmTyr1 protein, and staining mapped with high intensity to
honey bee brain neuropil areas. Some cell bodies immunolabeled
with low intensity compared to the neuropil, which could reflect
that the AmTyr1 receptor was translated in the cell body and
transported to axonal terminals. The present localization studies
on anti-AmTyr1 receptor protein distribution provide a further
confirmation of the previous work ofMustard et al. (2005), where
in situ hybridization of the AmTyr1 mRNA was reported to be
expressed in the mushroom body and antennal lobe neurons.
Anti-AmTyr1 immunolocalization studies revealed that in
the antennal lobe AmTyr1 is expressed in the presynaptic
sites of ORN axons as they innervate the cortex of glomeruli.
Similarly, in the mushroom body calyx, AmTyr1 is expressed
in the presynaptic sites of uPN axons located primarily in
the microglomeruli of the lip and basal ring calyx areas.
AmTyr1 is expressed in areas innervated by VUM (md and
mx) neurons. Therefore, release of tyramine from VUM (md
and mx) neurons in the antennal lobe and mushroom body
could target presynaptic sites of ORNs and uPNs (Figure 8).
Because the AmTyr1 receptor is similar in structure and function
to the vertebrate alpha-adrenergic receptor type 2 (Kuhar
et al., 1999), we hypothesize that the release of tyramine from
tyramine containing VUM neurons could inhibit excitatory
neurotransmitter release in the presynaptic axons of ORNs and
uPNs. The main excitatory neurotransmitter in ORNs and uPNs
is acetylcholine, which plays important roles in olfaction and
memory in bees (Gauthier, 2010). AmTyr1 in theses neurons
might be involved in regulation of the release of acetylcholine.
FIGURE 8 | Schematic view of the neural network proposed for the honey bee
antennal lobe (modified from Sinakevitch et al., 2013). Each glomerulus can be
defined by three types of neurons that are tuned to a narrow range of
odorants: (i) ORN axons that project excitatory branches into the cortex of the
glomerulus; (ii) the glomerular uPNs that receive input in both the cortex and
core of the glomerulus and project excitatory output branches to the LH and
Mushroom body calyx; and (iii) inhibitory hetero-LNs that branch in all areas of
the glomerulus (cortex and core), where they receive excitatory output from
the cortex and inhibitory from the core. Hetero-LNs also have inhibitory input
in the core area of one glomerulus. Hetero-LNs also have two types of
neurotransmitter (GABA and Histamine, Dacks et al., 2010). The neurons that
interconnect all glomeruli are multiglomerular LNs (containing both GABA and
Allatostatin, Kreissl et al., 2010). They have input/output branches in the core
area where they inhibit neurons in the core. There are also multiglomerular
inhibitory GABAergic mPNs that are not illustrated here. We propose that VUM
neurons release both octopamine and tyramine in the antennal lobe, LH and
mushroom body calyx. Each glomerulus will respond to the presence of each
biogenic amine through specific receptors. Inhibitory LNs (hetero and homo)
express AmOA1. The ORN axons express AmTyr1, and the uPNs axons in the
LH and Mushroom body calyx also express AmTyr1 receptors. In both cases,
AmTyr1 is in a position to regulate excitatory transmission into the respective
areas. We hypothesize that the action of octopamine and tyramine released by
VUM could be dependent on the ratio of the amines and on the specific target
cells that express the receptors. An excess of octopamine in a glomerulus
leads to inhibiting the inhibition in the core and simultaneously blocks
excitation in neighboring glomeruli via AmOA1 on GABAergic LNs. An excess
of tyramine inhibits the release of the excitatory neurotransmitter in the
synapses.
At the same time the release of octopamine from VUM neurons
could coordinate excitation via AmOA1 in inhibitory neurons in
the antennal lobe and mushroom bodies (Sinakevitch et al., 2013,
Figure 8).
AmTyr1 Receptors Are Expressed in Axons
of Kenyon Cells in the Lobe but Not in
Dendrites
Only subsets of KCs express the AmTyr1 receptor in the
axons and cell bodies, with a higher level of expression
in the axons compared to cell bodies. We did not find
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any detectable staining in the dendrites of KCs located
in calyx. In the KCs axons, AmTyr1 co-localized with
synapsin, the presynaptic marker of the neurons. In the
mushroom body lobe, the anti-AmTyr1 positive subsets of
KCs axons are in the pedunculus, lip, collar and basal ring
area of the lobe. The branching pattern of the KCs in the
mushroom body lobes was described in detail by Strausfeld
(2002).
Tyramine Receptor Distribution
in Comparison to Other Insects
Homolog of AmTyr1 have been studied in other insects: fruit
fly (TyrR, Oct/TyrR, TYR, Tar1, CG7485; Saudou et al., 1990;
El-Kholy et al., 2015); locust (Vanden Broeck et al., 1995);
silkworm (Ohta et al., 2003); and cockroach (PeaTyr1, Rotte
et al., 2009). Similar to AmTyr1, when investigated in expression
systems, these Tyr1 receptors were also negatively coupled to
adenylyl cyclase via Gi protein (Uzzan and Dudai, 1982; Aoyama
et al., 2001; Blenau and Baumann, 2003). However, activation
of locust and fruit fly Tyr1 receptors have also been shown to
mobilize intracellular calcium (Ohta and Ozoe, 2014). The brain
distribution of PeaTyr1 in the cockroach Periplaneta americana
is similar to our results with AmTyr1, but that report did not
identify specific neurons such as the presynaptic sites we show
here (Rotte et al., 2009). Additionally, they reported expression
in glial cells and peripherals organs. In our study, we also
report the possible expression of AmTyr1 in glial cells and
peripheral organs, but we did not illustrate it here. Expression
of the moth (Agrotis ipsilon) OA/TYR (AipsOAR/TAR) was
also reported in the antennae, the antennal lobes and the brain
and in the antennal lobes was shown to be regulated with age
(Duportets et al., 2010). In the fruit fly Drosophila melanogaster,
the expression pattern of TyrRs was studied by utilizing the
presumptive promotor regions of the TYR and the Gal4/UAS
system (El-Kholy et al., 2015). The fruit fly TyrRs are expressed in
the tracheal system, in salivary glands and in the mushroom body
and ellipsoid body, glial cells, fat body and muscles. However,
the fruit fly has three TYRs, one of which does not have an
ortholog in the honey bee (Tyr3), which makes it difficult to
compare our results on localization with the fruit fly (El-Kholy
et al., 2015).
Tyramine and AmTyr1 Receptors
in the Mushroom Body Lobe
It was striking in our study that the mushroom body α- and
γ-lobes do not have a high amount of tyraminergic (present
studies) or octopaminergic fibers (Sinakevitch et al., 2005)
in contrast to the calyx of the mushroom body and the
protocerebral area that surrounds mushroom body lobes.
However, the mushroom body lobes express both the AmTyr1
(present study) and AmOA1 receptors (Sinakevitch et al., 2011,
2013). We propose that the source of tyramine in the mushroom
body lobe could be from the hemolymph or from the release of
tyramine in the protocerebrum followed by diffusion into the
lobes. The presence of tyramine in the hemolymph was reported
in locust, and the level of tyramine is lower than octopamine in
brain tissue as well in the hemolymph.
It may be important for behavioral studies to consider
the ratio of tyramine and octopamine in the tissue rather
than focusing exclusively on a single amine, since they have
potentially antagonistic effects (Roeder, 2005). Fussnecker et al.
(2006) showed that honey bee flight behavior was affected
inversely by octopamine and tyramine treatment. Octopamine
increased flight behavior, while tyramine treatment decreased
it. Fussnecker et al. (2006) suggested that both biogenic
amines affect central pattern generators or interact with sensory
perception. Tyramine and octopamine have opposite effects on
locomotion in the fruit fly (Saraswati et al., 2004), and have been
shown (Brembs et al., 2007) to reduce fruit fly flight initiation.
Tyramine also reduces the stimulatory effect of octopamine in
the fly (Uzzan and Dudai, 1982). In the honey bee brain tyramine
is involved in habituation of an appetitive reflex (Braun and
Bicker, 1992) and in inhibition of the initiation of foraging
behaviors (Schulz and Robinson, 2001). High brain tyramine in
queenless honey bee workers might inhibit foraging behavior and
encourage them to stay in the nest and become reproductive
workers (Sasaki and Nagao, 2002).
CONCLUSION
One of the important findings in our studies is that tyramine
could originate from VUMmx and VUMmd neurons in the
antennal lobe, lateral protocerebrum and mushroom body calyx.
Our present tyramine mapping results in the honey bee are
consistent with reports on octopamine/tyramine containing cells
in locust (Kononenko et al., 2009; Homberg et al., 2013) and fruit
fly (Monastirioti et al., 1996; Monastirioti, 1999; Sinakevitch and
Strausfeld, 2006; Busch et al., 2009; Busch and Tanimoto, 2010;
Selcho et al., 2014). Our findings suggest that tyramine is not only
the precursor of octopamine but could also be an independent
neurotransmitter. From the AmTyr1 distribution, tyramine
targets the excitatory synapses of ORNs in glomeruli and of
PNs in the calyces of the mushroom bodies. From the similarity
to the vertebrate alpha 2 type adrenergic receptor, we suggest
that tyramine could inhibit release of the neurotransmitter
from both ORNs and PNs. Since the same neurons (VUMmd
and mx) have both tyramine and octopamine, it is possible
that the ratio of tyramine/octopamine in proximity to the
receptors plays a crucial role in the physiological responses
of the cells. Also, tyramine and octopamine could be released
in hemolymph, which brings additional complex response
in brain circuits as the hemolymph circulates through the
brain.
AUTHOR NOTE
During revision of our manuscript a new article about tyramine
and the AmTyr1 receptor (in this article the authors call
it ‘‘AmTAR1’’) was published (Thamm et al., 2017). The
authors developed new antibodies against AmTyr1 raised
against a cytoplasmic domain of the receptor, whereas our
antibodies targeted an extracellular domain. They described
staining in sections of the entire brain including the olfactory
neuropils, which was the exclusive focus of our work. The
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two studies show similar results in regard to the receptor in
the mushroom bodies but differ in regard to antennal lobe
staining. In our anti-tyramine staining, we used the same anti-
tyramine antibodies as Thamm et al. (2017), but we used a
different staining procedure. There were differences between
the studies in the number of tyraminergic cells and location
of tyramine in the mushroom body lobes. These differences in
tyramine and AmTyr1 receptor expression will require further
study.
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